[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100536439":3},{"organization":4,"armGroups":7,"interventions":14,"overallOfficials":10,"centralContacts":20,"locations":26,"responsibleParty":46,"collaborators":10,"id":48,"slug":49,"hasResults":50,"nctId":51,"briefTitle":52,"officialTitle":53,"acronym":54,"eligibilityCriteria":55,"healthyVolunteers":50,"sex":56,"minAge":57,"maxAge":10,"enrollmentInfo":58,"targetDuration":10,"studyType":61,"phases":10,"briefSummary":62,"conditions":63,"keywords":65,"overallStatus":29,"whyStopped":10,"lastUpdateSubmitDate":67,"lastUpdatePostDateStruct":68,"startDateStruct":71,"completionDateStruct":73,"leadSponsor":75,"locationsCount":76},{"fullName":5,"class":6},"Medistim ASA","INDUSTRY",[8],{"label":9,"type":10,"description":11,"interventionNames":12},"Patency of lower extremity vein bypass grafts",null,"Primary patency of lower extremity vein bypass grafts at one year",[13],"Device: MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes",[15],{"type":16,"name":17,"description":18,"armGroupLabels":19,"otherNames":10},"DEVICE","MiraQ with Transit-Time Flow Measurement (TTFM) and L15 High Frequency Ultrasound (HFUS) probes","Identify and validate intraoperative TTFM and HFUS findings (e.g. threshold values of Mean Graft Flow (MGF), MGF capacity, flow curve pattern, morphological issues)",[9],[21],{"name":22,"role":23,"phone":24,"phoneExt":10,"email":25},"Anne Waaler","CONTACT","+4790892713","anne.waaler@medistim.com",[27],{"facility":28,"status":29,"city":30,"state":31,"zip":32,"country":33,"countryCode":34,"cosmosGeoPoint":35,"geoPoint":40,"contacts":41},"University of California","RECRUITING","San Francisco","California","94143","United States","US",{"type":36,"coordinates":37},"Point",[38,39],-122.41942,37.77493,{"lat":39,"lon":38},[42],{"name":43,"role":23,"phone":44,"phoneExt":10,"email":45},"Michael Conte, MD","415-353-2256","michael.conte2@ucfs.edu",{"type":47,"investigatorFullName":10,"investigatorTitle":10,"investigatorAffiliation":10,"oldNameTitle":10,"oldOrganization":10},"SPONSOR","100536439","peripheral-bypass-trial-for-completion-control-100536439",false,"NCT06264843","Peripheral Bypass Trial for Completion Control","Open, Prospective, Multicentre Study Addressing the Immediate Benefits and the Prognostic Value of Intraoperative Completion Control Following Infrainguinal Bypass Surgery in Chronic Limb-Threatening Ischemia (CLTI) Patients","PATENT","Inclusion Criteria:\n\n* Chronic Limb-Threatening Ischemia as defined by presence of Peripheral Artery Disease (PAD) in combination with rest pain, gangrene, or a lower limb ulceration\\>2 weeks duration (ref Global Guidelines)\n* Atherosclerotic infra-popliteal PAD\n* Adequate distal anastomotic target (crural, tibial or popliteal below the knee with one single run-off) between knee and ankle distal to the stenotic\u002Foccluded segment.\n* Available autogenous vein conduit based on preoperative vein mapping.\n* Understand the nature of the procedure and willingness to comply with protocol. Attend follow-up appointments and provide written informed consent.\n\nExclusion Criteria:\n\n* Bypass with artificial conduit or cryopreserved allografts\n* Bypass for non-atherosclerotic lesions\n* Life-expectancy less than 2 years\n* Any psychological, developmental, physical or emotional disorder that the investigator believes would interfere with surgery or follow-up.\n* Any condition that the investigator believes should exclude participation.\n* Excessive risk for adverse events during open surgery as judged by the investigator.","ALL","18 Years",{"count":59,"type":60},450,"ESTIMATED","OBSERVATIONAL","The goal of the study is to identify and validate flow measurement and ultrasound images in patients undergoing vein bypass surgery below-knee and above ankle",[64],"Chronic Limb-Threatening Ischemia",[66],"CLTI","2025-10-13",{"date":69,"type":70},"2025-10-14","ACTUAL",{"date":72,"type":70},"2024-11-14",{"date":74,"type":60},"2027-12",{"name":5,"class":6},1]